Health Canada has approved the Oxford-AstraZeneca COVID-19 vaccine and a related shot by the Serum Institute of India for use in this country with the first doses expected to arrive soon.
CanAm Bioresearch Inc.
CanAm Bioresearch Inc. is a well-established pharmaceutical contract and research organization that specializes in pre-clinical discovery and development. It provides bioanalytical, pharmacokinetic, pharmacology, and custom chemical synthesis services. Its state-of-the-art 10,700 square foot research facility, located in Winnipeg, is also equipped with the most modern instruments, helping aid in the discovery of new drugs.
Founded in 2000, CanAm Bioresearchs’s team of experienced scientists assist in designing the best strategies to suit all drug discovery needs. The company guarantees its clients have full confidentiality and IP protection. Its QA Department also ensures the services its provides are high-quality.